Wire · regulatory
SEC And FDA Sign Memorandum Of Understanding Formalizing Cross-Agency Information Sharing
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 14 September 2026 · Fusion42 review
The SEC and FDA signed a memorandum of understanding to formalize the exchange of non-public information regarding FDA-regulated products and industries, increasing the likelihood of cross-agency investigations into misleading public disclosures by companies in these sectors.
This Wire brief sits within Fusion42's coverage of Health, and 3 sources have reported it between 5 Sep 2026 and 14 Sep 2026.
◆ ◆ The Wire takeaway
You must tighten coordination between your securities and regulatory teams now. Mixed messages about FDA matters will attract joint SEC-FDA investigations, raising your legal and market risks.
◆ Coverage
3 sources · first reported 5 Sep 2026 · latest 14 Sep 2026
◆ Related on Wire
◆ Topics